Analysen von Steve Chesney
| 17.03.15 | Bayer Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.03.15 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 10.03.15 | Bayer Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.15 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 22.12.14 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 11.11.14 | Bayer Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.14 | Merck Neutral | Goldman Sachs Group Inc. | |
| 06.11.14 | Bayer Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 30.10.14 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 22.09.14 | Merck Neutral | Goldman Sachs Group Inc. | |
| 18.08.14 | Merck Neutral | Goldman Sachs Group Inc. | |
| 06.08.14 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 25.07.14 | Merck Neutral | Goldman Sachs Group Inc. | |
| 04.07.14 | Merck Neutral | Goldman Sachs Group Inc. | |
| 14.05.14 | Merck Neutral | Goldman Sachs Group Inc. | |
| 14.05.14 | Bayer buy | Goldman Sachs Group Inc. | |
| 08.05.14 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 07.04.14 | Bayer buy | Goldman Sachs Group Inc. | |
| 26.03.14 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 19.03.14 | MorphoSys Neutral | Goldman Sachs Group Inc. | |